Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
189.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 11.00 (5.978%)
Market Cap: £3.51m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

Director/PDMR Shareholding

24 Aug 2020 10:59

RNS Number : 9763W
Norman Broadbent PLC
24 August 2020
 

Norman Broadbent plc

("Norman Broadbent" or the "Company")

Director/PDMR Shareholding

Norman Broadbent (AIM: NBB) - a leading London listed Professional Services firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services (Board & Leadership Search, Senior Interim Management, Research & Insight, Leadership Consulting & Assessment, and executive level Talent Solutions) - announces that Michael Brennan, Chief Executive Officer of the Company, purchased 15,000 ordinary shares of 1.0p each ("Ordinary Shares") in the Company at a price of 5p per share on Friday 21 August 2020.

Following this purchase, Mr Brennan is beneficially interested in 1,135,481 Ordinary Shares in Norman Broadbent representing approximately 2.11 per cent. of the Company's issued share capital.

For further information, please contact:

Norman Broadbent plcMike Brennan

Steve Smith

020 7484 0000

 

WH Ireland LimitedAdrian Hadden

Darshan Patel

Matthew Chan

 

020 7220 1666

  

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Michael Brennan

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Norman Broadbent PLC

b)

LEI

213800E5YN5TA934XA23

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

GB00B3VF4Y66

b)

Nature of the transaction

Purchase of shares for cash

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5p

15,000

d)

Aggregated information

Aggregated volume

Price

 

Purchase of 15,000 Ordinary Shares for 5 pence each, with a total price paid of £750

e)

Date of the transaction

21 August 2020

f)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDIRUDDGGS
Date   Source Headline
20th May 202610:40 amRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
8th May 20267:00 amRNSDirectorate Change
28th Apr 20265:25 pmRNSCourt Approval of Capital Reduction
22nd Apr 20267:00 amRNSPosting of Annual Report & Notice of AGM
21st Apr 20267:00 amRNSQ1 2026 Trading Update
20th Apr 20267:00 amRNSDirectorate Change
31st Mar 20269:11 amRNSTotal Voting Rights
26th Mar 20262:00 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSFinal Results
18th Mar 20268:00 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSProposed Capital Reduction
9th Mar 20269:23 amRNSReplacement- Results Notice/Investor Presentation
9th Mar 20267:00 amRNSNotice of Interim Results & Investor Presentation
25th Feb 20267:00 amRNSAcquisition And Total Voting Rights
6th Feb 20267:03 amRNSDirectorate Change
21st Jan 20267:00 amRNSDirectorate Change
15th Jan 20267:00 amRNSQ4 and FY25 Trading Update
13th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSChange of Auditor
8th Sep 20257:00 amRNSInterim Results
19th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
10th Jul 20257:00 amRNSH1 2025 Trading Update
19th Jun 20252:49 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
22nd May 202512:58 pmRNSResult of AGM, Capital Reorganisation and TVR
22nd May 20257:00 amRNSAGM Statement
22nd Apr 20257:00 amRNSPosting of ARA & Notice of AGM
2nd Apr 20257:00 amRNSQ1 2025 Trading Update and Final Results
4th Mar 20257:00 amRNSNotice of Results & Investor Presentation
16th Jan 20257:00 amRNSTrading Update
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.